Healthcare Services

One of the Major Drivers of the Oral Solid Dosage Contract Manufacturing Market Is the Increasing Demand For Generic Drugs Fuels Growth In The Oral Solid Dosage Contract Manufacturing Market

April 3, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Oral Solid Dosage Contract Manufacturing Market During 2026–2030?

The oral solid dosage contract manufacturing market size has experienced strong growth in recent years. It is projected to expand from $42.39 billion in 2025 to $45.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.6%. The expansion observed in the historic period can be attributed to factors such as increasing pressure to reduce in-house manufacturing costs, the rising complexity of oral solid dosage formulations, growing generic drug production volumes, limited internal manufacturing capacity of pharmaceutical companies, and an increasing reliance on third-party CMOs.

The oral solid dosage contract manufacturing market is projected to experience substantial expansion over the coming years. This market is forecast to reach $59.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. This anticipated growth is driven by several factors, including an escalating demand for scalable pharmaceutical production solutions, an expanding range of oral solid dosage drugs in development, increased investment in sophisticated manufacturing technologies, the broadening scope of pharmaceutical outsourcing in nascent markets, and a heightened requirement for agile and swift production capacities. Key trends expected during this period involve a surge in pharmaceutical companies’ outsourcing of oral solid dosage manufacturing, a greater need for large-volume and economical tablet and capsule manufacturing, the expanding use of modified and controlled-release oral solid dosage formulations, an intensified emphasis on regulatory adherence and quality assurance in contract manufacturing, and a rising inclination towards comprehensive manufacturing and packaging services.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16137&type=smp

Which Major Factors Are Driving The Expansion Of The Oral Solid Dosage Contract Manufacturing Market?

The future expansion of the oral solid dosage contract manufacturing market is anticipated, driven by the growing need for generic drugs. These medications mirror brand-name drugs across aspects like dosage, strength, safety, performance, quality, and their intended application. The increased appetite for generics stems from factors such as patents expiring, initiatives to control costs, encouraging regulations, and wider access to healthcare services. Oral solid dosage contract manufacturing plays a crucial role in the creation and supply of generic medicines, utilizing contract manufacturers’ expertise to boost efficiency, lower expenses, guarantee superior quality, and accelerate product launches. Illustratively, the Food and Drug Administration (FDA), a federal agency in the US, indicated that by 2025, more than 35,000 generic drugs received FDA approval, with 9 out of 10 prescriptions being for generics. Additionally, in November of 2024, the FDA issued over 800 updated Product-Specific Guidances (PSGs) for immediate-release solid oral generic drug products. Consequently, the sustained demand for generic drugs fuels the expansion of the oral solid dosage contract manufacturing market.

How Are The Various Segments Of The Oral Solid Dosage Contract Manufacturing Market Categorized?

The oral solid dosage contract manufacturing market covered in this report is segmented –

1) By Product Type: Tablets, Capsules, Powders, Granules, Other Product Types

2) By Service: Drug Product Development, Fill Finish Product Manufacturing, API Manufacturing, Packaging And Labelling, Other Applications

3) By Therapeutic Area: Oncology, Cardiovascular Diseases, Metabolic Disorders, Neurological Disorders, infectious Diseases, Gastrointestinal Diseases, Other Therapeutic Areas

4) By End User: Large Size Companies, Medium And Small Size Companies

Subsegments:

1) By Tablets: Compressed Tablets, Effervescent Tablets, Chewable Tablets, Coated Tablets, Sustained Or Controlled Release Tablets

2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Vegetarian Capsules, Liquid-Filled Capsules, Delayed Release Capsules

3) By Powders: Powders For Oral Suspension, Powders For Direct Compression, Powders For Mixing Or Blending, Instant Dissolving Powders

4) By Granules: Granules For Direct Compression, Granules For Tabletting, Effervescent Granules, Delayed Or Controlled Release Granules

5) By Other Product Types: Lozenges, Oral Strips, Oral Thin Films, Effervescent Tablets Or Granules

Which Trends Are Impacting The Growth Of The Oral Solid Dosage Contract Manufacturing Market?

Leading firms within the oral solid dosage contract manufacturing market are prioritizing the creation of advanced solutions, like continuous manufacturing systems, to maintain their competitive edge. Such a line denotes a production setup or facility employing uninterrupted manufacturing techniques for pharmaceutical or other product fabrication. An example of this is seen in January 2023, when WuXi STA, a pharmaceutical firm based in China, unveiled its inaugural continuous manufacturing line specifically for oral solid pharmaceutical goods. This state-of-the-art facility represents a major leap forward in drug production, utilizing continuous manufacturing principles to boost the efficiency, quality, and adaptability of drug production methods. This flexibility helps optimize production schedules and minimize idle periods, thereby speeding up the provision of essential medicines to those in need.

Which Major Firms Influence Developments In The Oral Solid Dosage Contract Manufacturing Market?

Major companies operating in the oral solid dosage contract manufacturing market are Evonik Industries AG, Teva Pharmaceutical Industries Ltd., Lonza Group AG, Catalent Inc., Patheon Pharma Services, Fareva Holding SA, Piramal Enterprises Limited, Hetero Drugs Limited, Siegfried Holding AG, Recipharm AB, Almac Group Limited, Aenova Holding GmbH, Jubilant Pharmova Limited, Cambrex Corporation, International Chemical Investors Group (ICIG) operates under CordenPharma, Ajinomoto Co. Inc., Hovione Holding Ltd., Alcami Corporation, NextPharma AB, Delpharm, PCI Pharma Services, Adare Pharma, Skyepharma

Read the full oral solid dosage contract manufacturing market report here:

https://www.thebusinessresearchcompany.com/report/oral-solid-dosage-contract-manufacturing-global-market-report

Which Region Currently Holds The Largest Share Of The Oral Solid Dosage Contract Manufacturing Market?

Asia-Pacific was the largest region in the oral solid dosage contract manufacturing market in 2025. The regions covered in the oral solid dosage contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oral Solid Dosage Contract Manufacturing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=16137&type=smp

Browse Through More Reports Similar to the Global Oral Solid Dosage Contract Manufacturing Market 2026, By The Business Research Company

Oral Care Global Market Report

https://www.thebusinessresearchcompany.com/report/oral-care-global-market-report

Dental Flap Surgery Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-flap-surgery-global-market-report

Mouthwash Global Market Report

https://www.thebusinessresearchcompany.com/report/mouthwash-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795